← Open Payments lookup

ERIC MARTINEZ: Open Payments

NPI 1952761868 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,493 in 132 payments from 21 companies in 2025. Trend: 2023 $624 · 2024 $1,308 · 2025 $6,493

Consulting: $2,500Food & beverage: $2,492Speaker / faculty: $800Travel & lodging: $701
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$4,502
Tris Pharma Inc7$295
ABBVIE INC.20$271
Janssen Pharmaceuticals, Inc11$183
E.R. Squibb & Sons, L.L.C.8$165
Otsuka America Pharmaceutical, Inc.11$162
Alkermes, Inc.12$148
Axsome Therapeutics, Inc.5$141
Collegium Pharmaceutical, Inc.5$91
Takeda Pharmaceuticals U.S.A., Inc.4$79

Products named: CAPLYTA, Dyanavel XR, VRAYLAR, REXULTI, COBENFY, ARISTADA, Auvelity, SPRAVATO.

Industry payments across IL — which companies pay providers there.